Abstract:Peptide-functionalized nanomedicine, which addresses the challenges of specificity and efficacy in drug delivery, is emerging as a pivotal approach for cancer therapy. Globally, cancer remains a leading cause of mortality, and conventional treatments, such as chemotherapy, often lack precision and cause adverse effects. The integration of peptides into nanomedicine offers a promising solution for enhancing the targeting and delivery of therapeutic agents. This review focuses on the three primary applications of peptides: cancer cell-targeting ligands, building blocks for self-assembling nanostructures, and elements of stimuli-responsive systems. Nanoparticles modified with peptides improved targeting of cancer cells, minimized damage to healthy tissues, and optimized drug delivery. The versatility of self-assembled peptide structures makes them an innovative vehicle for drug delivery by leveraging their biocompatibility and diverse nanoarchitectures. In particular, the mechanism of cell death induced by self-assembled structures offers a novel approach to cancer therapy. In addition, peptides in stimuli-responsive systems enable precise drug release in response to specific conditions in the tumor microenvironment. The use of peptides in nanomedicine not only augments the efficacy and safety of cancer treatments but also suggests new research directions. In this review, we introduce systems and functionalization methods using peptides or peptide-modified nanoparticles to overcome challenges in the treatment of specific cancers, including breast cancer, lung cancer, colon cancer, prostate cancer, pancreatic cancer, liver cancer, skin cancer, glioma, osteosarcoma, and cervical cancer.

Peptides in Cancer Nanomedicine: Drug Carriers, Targeting Ligands and Protease Substrates.

Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies

Polypeptides-Based Nanocarriers in Tumor Therapy

Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications

Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy

Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer

Applications of Peptide-based Nanomaterials in Targeting Cancer Therapy

Peptide Ligand-Mediated Targeted Drug Delivery of Nanomedicines.

Cancer Nanomedicines Based on Synthetic Polypeptides.

Peptide-Based Nanomaterials for Tumor Immunotherapy

Peptide ligand-mediated targeted drug delivery of nanomedicines

Novel Peptide Therapeutic Approaches for Cancer Treatment

Self-Assembled Peptide-Based Nanodrugs: Molecular Design, Synthesis, Functionalization, and Targeted Tumor Bioimaging and Biotherapy.

Peptide-decorated polymeric nanomedicines for precision cancer therapy.

Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers

Multifunctional peptides for tumor therapy

Protein-Based Artificial Nanosystems in Cancer Therapy

Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment

Peptide Self-Assembled Nanocarriers for Cancer Drug Delivery

Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy

Recent Advances of Nanocarriers for Effective Delivery of Therapeutic Peptides